No doubt my friend, all of these positive results, like I said the patents, the financial backing of a large company along with the research and development budget of a large company and the experience of bringing drugs to market and navigating the FDA, that is a big one, not screwing up all the little things the FDA looks at, that takes experienced people who know what they are doing. A buyout from the right company would benefit the buyer, Inovio, and all the people that will benefit from the groundbreaking work Inovio is doing.
News 
Market Data 
Discover 
